Atherosclerosis in Rheumatoid Arthritis Versus Diabetes

scientific article published on 16 July 2009

Atherosclerosis in Rheumatoid Arthritis Versus Diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/ATVBAHA.109.190108
P698PubMed publication ID19608975

P50authorAthanase D. ProtogerouQ38800530
Nicholas TentolourisQ83146175
Petros P SfikakisQ91233531
Vasileios F PanoulasQ91252622
Aamer SandooQ93021123
Kimon StamatelopoulosQ96193615
Christos M PapamichaelQ117263933
Katerina KyrkouQ117263934
Myron MavrikakisQ117263936
George D. KitasQ37831495
P2093author name stringGeorge Georgiopoulos
Elda Chryssohoou
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectrheumatoid arthritisQ187255
atherosclerosisQ12252367
P304page(s)1702-1708
P577publication date2009-07-16
P1433published inArteriosclerosis, Thrombosis, and Vascular BiologyQ4797542
P1476titleAtherosclerosis in rheumatoid arthritis versus diabetes: a comparative study
P478volume29

Reverse relations

cites work (P2860)
Q48370319Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation
Q83986921Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis
Q59303860Arterial hypertension assessed "out-of-office" in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated "white c
Q35814936Association of Cardiovascular Risk Factors with Carotid Intima Media Thickness in Patients with Rheumatoid Arthritis with Low Disease Activity Compared to Controls: A Cross-Sectional Study
Q37358225Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management?
Q92464675Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment
Q33943374Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment
Q35121150Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions
Q30355778Cardiovascular magnetic resonance imaging: clinical implications in the evaluation of connective tissue diseases.
Q44887210Carotid artery intima-media thickness in patients with autoimmune connective tissue diseases: a case-control study
Q59503688Comparison between conventional and automated software-guided ultrasound assessment of bilateral common carotids intima-media thickness in patients with rheumatic diseases
Q35892871Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation
Q37930979Ethnic differences in cardiovascular risk in rheumatic disease: focus on Asians
Q26774658High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms
Q35043956Histamine blood concentration in ischemic heart disease patients
Q90415124Important Considerations for Examining Endothelial Dysfunction in Rheumatoid Arthritis
Q99711818Incident arterial vascular events in a cohort of Puerto Ricans with rheumatoid arthritis
Q37689920Independent associations of total and high molecular weight adiponectin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study.
Q37058791Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion
Q35763883Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care setting.
Q37975943Managing cardiovascular risk in patients with chronic inflammatory diseases.
Q34343906Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus
Q39882466Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation.
Q89779990Microvascular Disease and Small-Vessel Disease: The Nexus of Multiple Diseases of Women
Q88347952Nocturnal blood pressure dipping is similar in rheumatoid arthritis patients as compared to a normal population
Q38098935Novel risk factors for cardiovascular disease in rheumatoid arthritis
Q36235589Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus
Q37413355Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages
Q36245670Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study
Q36270086Prevalence of Atherosclerosis in diabetic and non-diabetic patients with rheumatoid arthritis
Q37639995Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo
Q35025863Prostacyclin: an inflammatory paradox
Q41963156Rapidly evolving coronary aneurysm in a patient with rheumatoid arthritis
Q92550186Reactive Vasodilation Predicts Mortality in Primary Systemic Light-Chain Amyloidosis
Q59135667Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate
Q37691220Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study
Q60592413Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors
Q58051983Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis
Q36907729Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis
Q41264898Sudden cardiac death in patients with rheumatoid arthritis
Q89314644Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
Q83844887Tc-99m sestamibi lower extremity muscle scan, is it a useful screening tool for assessment of preclinical atherosclerosis in rheumatoid arthritis patients?
Q35730973The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus
Q57816912The Vasculopathy of Juvenile Dermatomyositis
Q33938590The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study.
Q36477400The beneficial effects of Tai Chi exercise on endothelial function and arterial stiffness in elderly women with rheumatoid arthritis
Q36788926The count of tender rather than swollen joints correlates with aortic stiffness in patients with rheumatoid arthritis
Q33547329The role of endothelial function and its assessment in rheumatoid arthritis.
Q34272487The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study
Q36907676The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study.
Q35904678The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease
Q90415636Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs
Q34164481Validated methods for assessment of subclinical atherosclerosis in rheumatology
Q64086396Values and Correlations between C-Reactive Protein and Apolipoprotein B after Treatment with Methotrexate at Patients with Rheumatoid Arthritis

Search more.